Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
1.
Lupus ; 27(9): 1499-1508, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29848166

ABSTRACT

Objective To investigate whether the aberrant expression of non-coding RNAs (ncRNAs) in T cells from patients with systemic lupus erythematosus (SLE) could contribute to the pathogenesis of lupus. Methods Expression profiles of RNA transcripts in T cells from three patients with SLE and three controls were analyzed by microarray analysis. Potentially aberrant-expressed ncRNAs were validated using T cell samples from 23 patients with SLE and 17 controls. Transfection studies and microarray analyses were conducted to search for any gene expression that is regulated by specific ncRNAs. Results Initial analysis revealed differential expression of 18 ncRNAs in SLE T cells. After validation, decreased expression of H/ACA box small nucleolar RNA 12 (SNORA12) was confirmed in SLE T cells (0.69-fold, P = 0.007) compared with normal T cells, and its expression level was inversely associated with higher SLE disease activity scores. Jurkat cells transfected with a plasmid encoding SNORA12 showed increased expression of two genes and decreased expression of 15 genes in Jurkat cells. These changes of gene expression were significantly associated with the SLE pathway in the Kyoto Encyclopedia of Genes and Genomes map using microarray analysis. Overexpression of SNORA12 altered the expression of CD69, decreased the expression of histone cluster 1 H4 family member k (HIST1H4K), inhibited the secretion of interferon gamma and the expression of HIST1H4K was increased in SLE T cells. Conclusion Among the ncRNAs, we found that the expression level of SNORA12, which belongs to the family of small nucleolar RNAs, was lower in SLE T cells and affected T cell function. This novel finding suggests that aberrant-expressed snoRNAs lead to dysfunction of T cells and may be involved in the immunopathogenesis of SLE.


Subject(s)
Lupus Erythematosus, Systemic/immunology , RNA, Small Nucleolar/metabolism , RNA, Untranslated/metabolism , T-Lymphocytes/metabolism , Adult , Case-Control Studies , Female , Gene Expression Profiling , Humans , Jurkat Cells , Male , Microarray Analysis , Middle Aged , Severity of Illness Index , Transfection
2.
Lupus ; 24(7): 687-94, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25406489

ABSTRACT

OBJECTIVE: The objective of this paper is to investigate the prevalence of reactivation of the human polyomavirus John Cunningham virus (JCV) in patients with systemic lupus erythematosus (SLE) and its associated clinical manifestations. METHODS: Sixty-one patients with SLE and 22 controls were enrolled. Urine JCV viral load was quantified by real-time polymerase chain reaction (PCR). Length variants of the VP1 gene were analyzed using capillary electrophoresis. RESULTS: The prevalence of JCV viruria (63.9% vs. 18.2%, p < 0.001) and urine JCV viral load (2.92 ± 2.76 vs. 0.81 ± 1.85 copies/ml by log10 scale, p < 0.001) were significantly higher in patients with SLE compared with controls. JCV viruria (+) SLE patients had a higher occurrence of arthritis/arthralgia compared with JCV viruria (-) SLE patients (64.1% vs. 22.7%, p = 0.003). In SLE patients, the urine JCV viral load was significantly associated with the occurrence of arthritis/arthralgia. SLE patients with urine JCV viral load >10,000 copies/ml exhibited a 12.75-fold (95% confidence interval 2.88-56.40) risk in clinical arthritis/arthralgia, 18.90-fold (95% confidence interval 2.10-170.39) risk in persistent arthritis, and significantly greater number of length variants in the VP1 gene of JCV compared with JCV viruria (-) SLE patients. CONCLUSION: Reactivation of JCV in the urinary tract of SLE patients was very common. Both JCV viruria and urine JCV viral load were associated with the occurrence of arthritis/arthralgia in patients with SLE. High urine JCV viral load also was associated with the genetic variant in the VP1 gene.


Subject(s)
Arthralgia/virology , Arthritis/virology , JC Virus/isolation & purification , Lupus Erythematosus, Systemic/virology , Polyomavirus Infections/virology , Adult , Aged , Arthralgia/urine , Arthritis/urine , Capsid Proteins/genetics , Capsid Proteins/metabolism , Case-Control Studies , DNA, Viral/genetics , DNA, Viral/urine , Electrophoresis, Capillary/methods , Female , Humans , JC Virus/genetics , Lupus Erythematosus, Systemic/urine , Male , Middle Aged , Polymerase Chain Reaction/methods , Polyomavirus Infections/urine , Prevalence , Sequence Analysis, DNA , Virus Activation
3.
Clin Exp Immunol ; 171(1): 91-9, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23199328

ABSTRACT

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with abnormal T cell immune responses. We hypothesized that aberrant expression of microRNAs (miRNAs) in T cells may contribute to the pathogenesis of SLE. First, we analysed the expression profiles of 270 human miRNAs in T cells from five SLE patients and five healthy controls and then validated those potentially aberrant-expressed miRNAs using real-time polymerase chain reaction (PCR). Then, the expression of mRNAs regulated by these aberrant-expressed miRNAs was detected using real-time PCR. Finally, miRNA transfection into Jurkat T cells was conducted for confirming further the biological functions of these miRNAs. The initial analysis indicated that seven miRNAs, including miR-145, miR-224, miR-513-5p, miR-150, miR-516a-5p, miR-483-5p and miR-629, were found to be potentially abnormally expressed in SLE T cells. After validation, under-expressed miR-145 and over-expressed miR-224 were noted. We further found that STAT1 mRNA targeted by miR-145 was over-expressed and apoptosis inhibitory protein 5 (API5) mRNA targeted by miR-224 was under-expressed in SLE T cells. Transfection of Jurkat cells with miR-145 suppressed STAT1 and miR-224 transfection suppressed API5 protein expression. Over-expression of miR-224 facilitates activation-induced cell death in Jurkat cells. In the clinical setting, the increased transcript levels of STAT1 were associated significantly with lupus nephritis. In conclusion, we first demonstrated that miR-145 and miR-224 were expressed aberrantly in SLE T cells that modulated the protein expression of their target genes, STAT1 and API5, respectively. These miRNA aberrations accelerated T cell activation-induced cell death by suppressing API5 expression and associated with lupus nephritis by enhancing signal transducer and activator of transcription-1 (STAT)-1 expression in patients with SLE.


Subject(s)
Lupus Erythematosus, Systemic/immunology , MicroRNAs/biosynthesis , T-Lymphocytes/immunology , Adult , Apoptosis/genetics , Apoptosis Regulatory Proteins/biosynthesis , Female , Humans , Jurkat Cells , Male , MicroRNAs/genetics , Middle Aged , Nuclear Proteins/biosynthesis , STAT1 Transcription Factor/biosynthesis , Transcriptome , Transfection
4.
Clin Exp Immunol ; 168(1): 78-86, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22385242

ABSTRACT

Abnormal Ca(2+) -mediated signalling contributes to the pathogenesis of rheumatoid arthritis (RA). However, the potential implication of calcium channel blocker in RA remained unknown. We hypothesized that nifedipine, an L-type calcium channel blocker, combined with a calcineurin inhibitor, could suppress T cell activation via targeting different level of the Ca(2+) signalling pathway. The percentage of activated T cells and the apoptotic rate of mononuclear cells (MNCs) was measured by flow cytometry. The MNC viability, cytokine production, cytosolic Ca(2+) level and activity of the nuclear factor of activated T cells (NFAT) were measured by enzyme-linked immunosorbent assay (ELISA). The NFAT-regulated gene expression, including interleukin (IL)-2, interferon (IFN)-γ and granulocyte-macrophage colony-stimulating factor (GM-CSF), was measured by real-time polymerase chain reaction (PCR). We found that the percentage of activated T cells in anti-CD3 + anti-CD28-activated MNC was higher in RA patients. High doses of nifedipine (50 µM) increased MNCs apoptosis, inhibited T cell activation and decreased T helper type 2 (Th1) (IFN-γ)/Th2 (IL-10) cytokine production in both groups. The Ca(2+) influx was lower in anti-CD3 + anti-CD28-activated MNC from RA patients than healthy volunteers and suppressed by nifedipine. When combined with a subtherapeutic dose (50 ng/ml) of cyclosporin, 1 µM nifedipine suppressed the percentage of activated T cells in both groups. Moreover, this combination suppressed more IFN-γ secretion and NFAT-regulated gene (GM-CSF and IFN-γ) expression in RA-MNCs than normal MNCs via decreasing the activity of NFATc1. In conclusion, we found that L-type Ca(2+) channel blockers and subtherapeutic doses of cyclosporin act additively to suppress the Ca(2+) -calcineurin-NFAT signalling pathway, leading to inhibition of T cell activity. We propose that this combination may become a potential treatment of RA.


Subject(s)
Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/immunology , Calcineurin/metabolism , Cyclosporine/administration & dosage , Leukocytes, Mononuclear/immunology , Nifedipine/administration & dosage , T-Lymphocytes/immunology , Adult , Aged , Apoptosis/drug effects , Arthritis, Rheumatoid/metabolism , Calcineurin Inhibitors , Calcium/metabolism , Calcium Channel Blockers/administration & dosage , Calcium Channel Blockers/pharmacology , Calcium Channel Blockers/therapeutic use , Cyclosporine/pharmacology , Cyclosporine/therapeutic use , Drug Therapy, Combination , Enzyme-Linked Immunosorbent Assay , Female , Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Humans , Interferon-gamma/antagonists & inhibitors , Interferon-gamma/biosynthesis , Interferon-gamma/genetics , Interleukin-10/metabolism , Interleukin-2/biosynthesis , Interleukin-2/genetics , Leukocytes, Mononuclear/metabolism , Lymphocyte Activation , Male , Middle Aged , NFATC Transcription Factors/biosynthesis , Nifedipine/pharmacology , Nifedipine/therapeutic use , Real-Time Polymerase Chain Reaction , Signal Transduction/drug effects , T-Lymphocytes/metabolism
5.
Gene Ther ; 18(12): 1173-8, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21900963

ABSTRACT

Adeno-associated virus (AAV)-mediated gene replacement for lysosomal disorders have been spurred by the ability of some serotypes to efficiently transduce neurons in the brain and by the ability of lysosomal enzymes to cross-correct among cells. Here, we explored enzyme replacement therapy in a knock-out mouse model of congenital neuronal ceroid lipofuscinosis (NCL), the most severe of the NCLs in humans. The missing protease in this disorder, cathepsin D (CathD) has high levels in the central nervous system. This enzyme has the potential advantage for assessing experimental therapy in that it can be imaged using a near-infrared fluorescence (NIRF) probe activated by CathD. Injections of an AAV2/rh8 vector-encoding mouse CathD (mCathD) into both cerebral ventricles and peritoneum of newborn knock-out mice resulted in a significant increase in lifespan. Successful delivery of active CathD by the AAV2/rh8-mCathD vector was verified by NIRF imaging of mouse embryonic fibroblasts from knock-out mice in culture, as well as by ex vivo NIRF imaging of the brain and liver after gene transfer. These studies support the potential effectiveness and imaging evaluation of enzyme replacement therapy to the brain and other organs in CathD null mice via AAV-mediated gene delivery in neonatal animals.


Subject(s)
Cathepsin D/genetics , Fluorescent Dyes , Gene Transfer Techniques , Genetic Therapy/methods , Infrared Rays , Neuronal Ceroid-Lipofuscinoses/therapy , Animals , Animals, Newborn , Brain Chemistry , Dependovirus/genetics , Disease Models, Animal , Enzyme Replacement Therapy/methods , Genetic Vectors , Liver/chemistry , Mice , Mice, Inbred C57BL , Mice, Knockout , Neuronal Ceroid-Lipofuscinoses/genetics
7.
J Nanosci Nanotechnol ; 8(5): 2568-74, 2008 May.
Article in English | MEDLINE | ID: mdl-18572685

ABSTRACT

Copper films with high density of twin boundaries are known for high mechanical strength with little tradeoff in electrical conductivity. To achieve such a high density, twin lamellae and spacing will be on the nanoscale. In the current study, 10 microm copper films were prepared by pulse electrodeposition with different applied pulse peak current densities and pulse on-times. It was found that the deposits microstructure was dependent on the parameters of pulse plating. Higher energy pulses caused stronger self-annealing effect on grain recrystallization and growth, thus leading to enhanced fiber textures, while lower energy pulses gave rise to more random microstructure in the deposits and rougher surface topography. However in the extremes of pulse currents we applied, the twin densities were not as high as those resulted from the medium or relatively high pulse currents. The highest amount of nanoscale twinning was found to form from a proper degree of self-annealing induced grain structure evolution. The driving force behind the self-annealing is discussed.

8.
Cancer Res ; 64(12): 4069-77, 2004 Jun 15.
Article in English | MEDLINE | ID: mdl-15205313

ABSTRACT

We have shown previously that urokinase plasminogen activator receptor (uPAR) and cathepsin B are overexpressed during glioma progression, particularly at the leading edge of the tumor. In the present study, we simultaneously down-regulated uPAR and cathepsin B in SNB19 glioma cell monolayer or SNB19 spheroids using an adenoviral vector carrying antisense uPAR and antisense cathepsin B and a combination of these genes as determined by Western blot analysis. The Ad-uPAR-Cath B-infected cells revealed a marked reduction in tumor growth and invasiveness as compared with the parental and vector controls. In vitro and in vivo angiogenic assays demonstrated inhibition of capillary-like structure formation and microvessel formation after Ad-uPAR-Cath B infection of SNB19 cells when compared with Ad-cytomegalovirus (CMV)-infected or mock-infected controls. Furthermore, using a near infrared fluorescence probe, in vivo imaging for cathepsin B indicated low/undetectable levels of fluorescence after injection of the Ad-uPAR-Cath B construct into pre-established s.c. tumors as compared with Ad-CMV-treated and untreated tumors. The effect with bicistronic construct (Ad-uPAR-Cath B) was much higher than with single (Ad-uPAR/Ad-Cath B) constructs. These results indicate that the down-regulation of cathepsin B and uPAR plays a significant role in inhibiting tumor growth, invasion, and angiogenesis. Hence, the targeting of these two proteases may be a potential therapy for brain tumors and other cancers.


Subject(s)
Cathepsin B/antagonists & inhibitors , DNA, Antisense/genetics , Glioblastoma/genetics , Glioblastoma/therapy , Neovascularization, Pathologic/genetics , Neovascularization, Pathologic/therapy , Receptors, Cell Surface/antagonists & inhibitors , Adenoviridae/genetics , Animals , Cathepsin B/genetics , Cell Division/genetics , Cell Movement/genetics , DNA, Antisense/administration & dosage , Female , Genetic Therapy/methods , Glioblastoma/blood supply , Glioblastoma/virology , Humans , Male , Mice , Mice, Nude , Neoplasm Invasiveness , Neovascularization, Pathologic/pathology , Receptors, Cell Surface/genetics , Receptors, Urokinase Plasminogen Activator , Spheroids, Cellular , Xenograft Model Antitumor Assays
9.
Radiology ; 221(2): 523-9, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11687699

ABSTRACT

PURPOSE: To develop an optical imaging method to determine the expression level of tumoral matrix metalloproteinase-2 (MMP-2) in vivo. MATERIALS AND METHODS: An optical contrast agent was developed that was highly activatable by means of MMP-2-induced conversion. Signal characteristics of the probe were quantified ex vivo with a recombinant enzyme. Animal tumor models were established with MMP-2-positive (human fibrosarcoma cell line, n = 4) and MMP-2-negative (well-differentiated mammary adenocarcinoma, n = 4) tumor cell lines. Both tumors were implanted into nude mice and were optically imaged after intravenous administration of the MMP-2-sensitive probe. RESULTS: The MMP-2-sensitive probe was activated by MMP-2 in vitro, producing up to an 850% increase in near-infrared fluorescent signal intensity. This activation could be blocked by MMP-2 inhibitors. MMP-2-positive tumors were easily identified as high-signal-intensity regions as early as 1 hour after intravenous injection of the MMP-2 probe, while contralateral MMP-2-negative tumors showed little to no signal intensity. A nonspecific control probe showed little to no activation in MMP-2-positive tumors. CONCLUSION: It is feasible to image MMP-2 enzyme activity in vivo by using near-infrared optical imaging technology and "smart" matrix metalloproteinase-sensitive probes.


Subject(s)
Matrix Metalloproteinase 2/metabolism , Neoplasms, Experimental/enzymology , Animals , Chemistry Techniques, Analytical/methods , Feasibility Studies , Matrix Metalloproteinase 2/biosynthesis , Mice , Mice, Nude , Spectrum Analysis/methods
10.
Nat Med ; 7(6): 743-8, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11385514

ABSTRACT

A number of different matrix metalloproteinase (MMP) inhibitors have been developed as cytostatic and anti-angiogenic agents and are currently in clinical testing. One major hurdle in assessing the efficacy of such drugs has been the inability to sense or image anti-proteinase activity directly and non-invasively in vivo. We show here that novel, biocompatible near-infrared fluorogenic MMP substrates can be used as activatable reporter probes to sense MMP activity in intact tumors in nude mice. Moreover, we show for the first time that the effect of MMP inhibition can be directly imaged using this approach within hours after initiation of treatment using the potent MMP inhibitor, prinomastat (AG3340). The developed probes, together with novel near-infrared fluorescence imaging technology will enable the detailed analysis of a number of proteinases critical for advancing the therapeutic use of clinical proteinase inhibitors.


Subject(s)
Antineoplastic Agents/therapeutic use , Fluorescent Dyes/metabolism , Matrix Metalloproteinase Inhibitors , Neoplasms, Experimental/drug therapy , Organic Chemicals , Protease Inhibitors/therapeutic use , Spectroscopy, Near-Infrared/methods , Animals , Antineoplastic Agents/pharmacology , Cell Line , Diagnostic Imaging , Fibrosarcoma/drug therapy , Fibrosarcoma/physiopathology , Fluorescence , Fluorescent Dyes/chemistry , Humans , Mammary Neoplasms, Experimental/drug therapy , Mammary Neoplasms, Experimental/physiopathology , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinases/metabolism , Mice , Mice, Nude , Neoplasms, Experimental/pathology , Neoplasms, Experimental/physiopathology , Peptides/chemistry , Peptides/metabolism , Protease Inhibitors/pharmacology
11.
Bioconjug Chem ; 12(2): 213-9, 2001.
Article in English | MEDLINE | ID: mdl-11312682

ABSTRACT

Angiogenesis is a critical step in tumor development and more than 25 angiogenesis inhibitors are currently in clinical trials. Noninvasive in vivo imaging of angiogenesis represents a unique opportunity of repeatedly quantitating microvascular parameters prior to and during anti-angiogenic treatments. While several imaging tracers have been proposed for MR and nuclear imaging, there does not exist any consensus of what constitutes an ideal size of an imaging agent. A series of synthetic pegylated DOTA derivatized graft copolymers (30, 60, 120 kDa) were synthesized and their in vivo behavior tested in two breast cancer models differing in vascular endothelial growth factor (VEGF) expression. Polymers were labeled with different lanthanides (Eu, Gd, Dy) and absolute blood and tumor concentrations were determined by ICP-AES measurements. DOTA and the 30 kDa polymers underwent renal clearance resulting in low plasma levels. Slow leakage across neovasculature into tumor interstitium was clearly dependent on the molecular mass of all tested agents in MCF-7 tumors. However, a cutoff was observed with minimal extravasation occurring at and above 120 kDa in well differentiated MCF-7 tumors. VEGF overexpression caused detectable differences in extravasation of all polymers, including the 120 kDa compound. We conclude that large molecular weight contrast agents with a molecular mass of <120 kDa extravasate from experimental tumor neovasculature and may not be an accurate marker for measuring true blood volume fractions when in vivo imaging is performed in the steady state.


Subject(s)
Contrast Media/metabolism , Endothelial Growth Factors/metabolism , Extravasation of Diagnostic and Therapeutic Materials , Lymphokines/metabolism , Mammary Neoplasms, Experimental/pathology , Neovascularization, Pathologic , Polyethylene Glycols/chemistry , Animals , Contrast Media/chemical synthesis , Contrast Media/chemistry , Female , Heterocyclic Compounds, 1-Ring/chemistry , Humans , Magnetic Resonance Imaging , Mammary Neoplasms, Experimental/metabolism , Mammary Neoplasms, Experimental/physiopathology , Metals, Rare Earth/chemistry , Metals, Rare Earth/metabolism , Mice , Mice, Nude , Microscopy, Fluorescence , Molecular Structure , Molecular Weight , Neoplasm Transplantation , Particle Size , Polyethylene Glycols/metabolism , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
12.
Gene Ther ; 8(7): 515-22, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11319618

ABSTRACT

Noninvasive in vivo monitoring of gene delivery would provide a critically important information regarding the spatial distribution, local concentration, kinetics of removal and/or biodegradation of the expression vector. We developed a novel approach to noninvasive gene delivery imaging using heterobifunctional peptide-based chelates (PBC) bearing double-stranded DNA-binding groups and a technetium-binding amino acid motif. One of such chelates: Gly-Cys(Acm)-Gly-Cys(Acm)-Gly-Lys(4)-Lys-(N-epsilon-[4-(psoralen-8-yloxy)]butyrate)-NH(2) has been characterized and labeled with reduced (99m)Tc pertechnetate (oxotechnetate). The psoralen moiety (a DNA binding group of PBC) allowed linking to double-stranded DNA upon short-term irradiation with the near UV range light (>320 nm). Approximately 30-40% of added (99m)Tc-labeled PBC was nonextractable and co-eluted with a model pCMV-GFP vector during the gel-permeation chromatography. Nuclear imaging of "naked" DNA and DNA complexes with lipid-based transfection reagents ("lipoplexes") has been performed after systemic or local administration of (99m)Tc-PBC-labeled DNA in mice. Imaging results were corroborated with the biodistribution using (99m)Tc-PBC and (32)P-labeled DNA and lipoplexes. A markedly different biodistribution of (99m)Tc PBC-labeled DNA and lipoplexes was observed with the latter being rapidly trapped in the liver, spleen and lung. (99m)Tc PBC-DNA was used as an imaging tracer during in vivo transfection of B16 melanoma by local injection of "naked" (99m)Tc PBC-DNA and corresponding lipoplexes. As demonstrated by nuclear imaging, (99m)Tc PBC-DNA lipoplexes showed a slower elimination from the site of injection than (99m)Tc PBC-DNA alone. This result correlated with a higher expression of marker mRNA and green fluorescent protein as determined using RT-PCR and immunohistochemistry, respectively.


Subject(s)
DNA/pharmacokinetics , Gene Transfer Techniques , Genetic Vectors/pharmacokinetics , Animals , Chelating Agents , Female , Melanoma, Experimental/diagnostic imaging , Melanoma, Experimental/metabolism , Mice , Mice, Inbred C57BL , Mice, Nude , Radionuclide Imaging , Technetium , Tissue Distribution , Transfection
13.
N Engl J Med ; 344(17): 1293, 2001 Apr 26.
Article in English | MEDLINE | ID: mdl-11320388
14.
Radiologe ; 41(2): 131-7, 2001 Feb.
Article in German | MEDLINE | ID: mdl-11253098

ABSTRACT

Different optical imaging technologies have significantly progressed over the last years. Besides advances in imaging techniques and image reconstruction, new "smart" optical contrast agents have been developed which can be used to detect molecular targets (such as endogenous enzymes) in vivo. The combination of novel imaging technologies coupled with smart agents bears great diagnostic potential both clinically and experimentally. This overview outlines the basic principles of optical imaging and summarizes the current state of the art.


Subject(s)
Image Enhancement/methods , Optics and Photonics , Tomography/methods , Animals , Contrast Media , Fluorescent Dyes , Humans , Spectroscopy, Near-Infrared/methods , Transillumination/methods
15.
Chem Commun (Camb) ; (21): 2280-1, 2001 Nov 07.
Article in English | MEDLINE | ID: mdl-12240150

ABSTRACT

The non-emissive platinum(II)-quaterpyridine complex shows strong photoluminescence at room temperature upon incorporation into Nafion membrane; this complex is stabilized toward photochemical decomposition in Nafion even in the presence of oxygen, and can be used as a sensitizer to generate singlet oxygen to oxidize alkenes.

16.
Cancer Res ; 60(17): 4953-8, 2000 Sep 01.
Article in English | MEDLINE | ID: mdl-10987312

ABSTRACT

The single biggest challenge facing in vivo imaging techniques is to develop biocompatible molecular beacons that are capable of specifically and accurately measuring in vivo targets at the protein, RNA, or DNA level. Our efforts have focused on developing activatable imaging probes to measure specific enzyme activities in vivo. Using cathepsin D as a model target protease, we synthesized a long-circulating, synthetic graft copolymer bearing near-infrared (NIR) fluorochromes positioned on cleavable substrate sequences. In its native state, the reporter probe was essentially nonfluorescent at 700 nm due to energy resonance transfer among the bound fluorochromes (quenching) but became brightly fluorescent when the latter were released by cathepsin D. NIR fluorescence signal activation was linear over at least 4 orders of magnitude and specific when compared with scrambled nonsense substrates. Using matched rodent tumor models implanted into nude mice expressing or lacking the targeted protease, it could be shown that the former generated sufficient NIR signal to be directly detectable and that the signal was significantly different compared with negative control tumors. The developed probes should find widespread applications for real-time in vivo imaging of a variety of clinically relevant proteases, for example, to detect endogenous protease activity in disease, to monitor the efficacy of protease inhibitors, or to image transgene expression.


Subject(s)
Fluorescent Dyes/metabolism , Peptide Hydrolases/metabolism , Animals , Cathepsin D/metabolism , Image Processing, Computer-Assisted/methods , Mice , Mice, Nude , Neoplasm Transplantation , Neoplasms, Experimental/enzymology , Oligopeptides/metabolism , Polyethylenes/metabolism , Polylysine/analogs & derivatives , Polylysine/metabolism , Rats , Reverse Transcriptase Polymerase Chain Reaction/methods , Spectroscopy, Near-Infrared/methods , Substrate Specificity , Tumor Cells, Cultured
18.
Pharm Res ; 17(4): 451-9, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10870990

ABSTRACT

PURPOSE: To design, synthesize, and test synthetic glycopeptide-based delivery systems for gene targeting to hepatocytes by systemic administration. METHODS: All peptides were synthesized by the solid phase method developed using Fmoc chemistry on a peptide synthesizer. The binding of galactosylated peptides to HepG2 cells and accessibility of the galactose residues on particle surface was demonstrated by a competition assay using 125I-labeled asialoorosomucoid and RCA lectin agglutination assay, respectively. DNA plasmid encoding chloramphenicol acetyl transferase (CAT) gene was complexed with a tri-galactosylated peptide (GM245.3) or tri-galactosylated lipopeptide (GM246.3) in the presence of an endosomolytic peptide (GM225.1) or endosomolytic lipopeptide (GM227.3) to obtain DNA particles of 100-150 nm in size. The plasmid/peptide complexes were added to HepG2 cell cultures or intravenously administered by tail vein injection into normal mice or rats. Plasmid uptake and expression was quantified by qPCR and ELISA, respectively. RESULTS: Multiple antennary glycopeptides that have the ability to condense and deliver DNA plasmid to hepatocytes were synthesized and complexed with DNA plasmid to obtain colloidally stable DNA/peptide complexes. Addition of DNA/GM245.3/GM225.1 peptide complexes (1:3:1 (-/+/-)) to HepG2 cell cultures yielded CAT expression in transfected cells. The transfection efficiency was significantly reduced in the absence of galactose ligand or removal of endosomolytic peptide. Intravenous administration of DNA/GM245.3 peptide complexes (1:0.5 (-/+)) into the tail vein of normal rats yielded DNA uptake in the liver. Substitution of GM245.3 by galactosylated lipopeptide GM246.3 resulted in more stable DNA particles, and a 10-fold enhancement in liver plasmid uptake. CAT expression was detectable in liver following intravenous administration of DNA/GM246.3 complexes. Addition of endosomolytic lipopeptide GM227.3 into the complexes (DNA/ GM246.3/GM227.3 (1:0.5:1 (-/+/-))) yielded a 5-fold increase in CAT expression. Liver expression was 8-fold and 40-fold higher than lung and spleen, respectively, and localized in the hepatocytes only. The transfection efficiency in liver was enhanced by increasing DNA dose and injection volume. The plasmid uptake and expression in liver using DNA/GM246.3/GM227.3 complexes was 100-200-fold higher than DNA formulated in glucose. Tissue examination and serum biochemistry did not show any adverse effect of the DNA/GM246.3/ GM227.3 (1:0.5:1 (-/+/-)) complexes after intravenous delivery. CONCLUSIONS: Gene targeting to hepatocytes was achieved by systemic administration of a well-tolerated synthetic glycopeptide-based delivery system. The transfection efficiency of this glycopeptide delivery system was dependent on peptide structure, endosomolytic activity, colloidal particle stability, and injection volume.


Subject(s)
Gene Targeting , Glycopeptides/chemistry , Liver/metabolism , Amino Acid Sequence , Animals , Cells, Cultured , Chloramphenicol O-Acetyltransferase/genetics , Gene Expression , Glycopeptides/chemical synthesis , Glycopeptides/genetics , Liver/cytology , Mice , Molecular Sequence Data , Plasmids , Rats , Rats, Sprague-Dawley
19.
Bioconjug Chem ; 11(3): 301-5, 2000.
Article in English | MEDLINE | ID: mdl-10821645

ABSTRACT

A major obstacle to using paramagnetic MR contrast agents for in vivo cell tracking or molecular sensing is their generally low cellular uptake. In this study, we show that a paramagnetically labeled DOTA chelator derivatized with a 13-mer HIV-tat peptide is efficiently internalized into mammalian cells. Intracellular concentrations were attained that were readily detectable by MR imaging using both gadolinium and dysprosium chelates. Using this paradigm, it should be feasible to internalize a variety of chemically different agents into mammalian cells.


Subject(s)
Chelating Agents/metabolism , Gene Products, tat/metabolism , Heterocyclic Compounds, 1-Ring/metabolism , Magnetic Resonance Imaging , Peptide Fragments/metabolism , Amino Acid Sequence , Animals , Biological Transport , Cell Membrane/metabolism , Cell Nucleus/metabolism , Cytoplasm/metabolism , Dysprosium , Gadolinium , Gene Products, tat/chemical synthesis , Gene Products, tat/chemistry , HeLa Cells , Heterocyclic Compounds, 1-Ring/chemical synthesis , Heterocyclic Compounds, 1-Ring/chemistry , Humans , Indium Radioisotopes , Lymphocytes/metabolism , Lymphocytes/ultrastructure , Mice , Molecular Sequence Data , Peptide Fragments/chemistry , tat Gene Products, Human Immunodeficiency Virus
20.
Nat Biotechnol ; 18(4): 410-4, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10748521

ABSTRACT

The ability to track the distribution and differentiation of progenitor and stem cells by high-resolution in vivo imaging techniques would have significant clinical and research implications. We have developed a cell labeling approach using short HIV-Tat peptides to derivatize superparamagnetic nanoparticles. The particles are efficiently internalized into hematopoietic and neural progenitor cells in quantities up to 10-30 pg of superparamagnetic iron per cell. Iron incorporation did not affect cell viability, differentiation, or proliferation of CD34+ cells. Following intravenous injection into immunodeficient mice, 4% of magnetically CD34+ cells homed to bone marrow per gram of tissue, and single cells could be detected by magnetic resonance (MR) imaging in tissue samples. In addition, magnetically labeled cells that had homed to bone marrow could be recovered by magnetic separation columns. Localization and retrieval of cell populations in vivo enable detailed analysis of specific stem cell and organ interactions critical for advancing the therapeutic use of stem cells.


Subject(s)
Gene Products, tat/pharmacokinetics , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/cytology , Peptide Fragments/pharmacokinetics , Animals , Antigens, CD/analysis , Antigens, CD34/analysis , Bone Marrow Cells/cytology , Cell Differentiation , Cell Division , Cell Survival , Colony-Forming Units Assay , Ferric Compounds , Gene Products, tat/chemistry , HIV-1 , Humans , Injections, Intravenous , Magnetic Resonance Imaging , Magnetics , Mice , Mice, Inbred NOD , Mice, SCID , Nervous System/cytology , Stem Cells/cytology , Transplantation, Heterologous , tat Gene Products, Human Immunodeficiency Virus
SELECTION OF CITATIONS
SEARCH DETAIL
...